Elicio Therapeutics, Inc.
41 SEC EDGAR filings indexed (CIK 0001601485) across 12 form types.
Filing profile
Elicio Therapeutics, Inc. (ELTX) has 41 SEC filings indexed on SecFilingDex, across 12 form types filed over roughly 2 years, from April 29, 2024 to August 13, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).
Its most frequent disclosure is the 8-K (Material event) with 8 filings — Current report announcing a material event, such as an acquisition, executive change, or earnings release. 23 of these filings were disclosed in the twelve months to August 13, 2026. 5 of the 41 are amendments (a corrected or updated version of an earlier filing).
Disclosure mix
- 88-KMaterial event · event-driven
- 810-QQuarterly report · quarterly
- 8Form 4Insider transaction · within 2 business days of transaction
- 5424B5Prospectus supplement · event-driven
- 210-K/AAnnual report · annual
- 210-KAnnual report · annual
- 2DEF 14AProxy statement · annual (pre-meeting)
- 2SC 13D/A5%+ activist stake · event-driven (within 10 days)
- 1Form 3Initial insider ownership · within 10 days of becoming an insider
- 1Form 4/AInsider transaction · within 2 business days of transaction
- 1424B3Updated prospectus · event-driven
- 1PRE 14ASEC filing
Profile derived from 41 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.
All filings
- 8-KMaterial event · period of report Aug 13, 2026Filed · 0001601485-26-000055
- 10-QQuarterly report · period of report Jun 30, 2026Filed · 0001601485-26-000056
- Form 4Insider transaction · period of report Jul 16, 2026Filed · 0001612095-26-000002
- Form 4Insider transaction · period of report Jul 16, 2026Filed · 0001787403-26-000002
- Form 4Insider transaction · period of report Jul 16, 2026Filed · 0001796436-26-000002
- Form 4Insider transaction · period of report Jul 16, 2026Filed · 0001979163-26-000002
- 8-KMaterial event · period of report Jul 1, 2026Filed · 0001104659-26-080058
- 424B5Prospectus supplementFiled · 0001104659-26-080106
- 8-KMaterial event · period of report Jun 24, 2026Filed · 0001601485-26-000050
- 8-KMaterial event · period of report Jun 17, 2026Filed · 0001601485-26-000048
- 8-KMaterial event · period of report Jun 15, 2026Filed · 0001601485-26-000046
- 8-KMaterial event · period of report May 11, 2026Filed · 0001601485-26-000041
- 10-QQuarterly report · period of report Mar 31, 2026Filed · 0001601485-26-000042
- 10-K/AAnnual report · period of report Dec 31, 2025Filed · 0001601485-26-000035
- 8-KMaterial event · period of report Mar 16, 2026Filed · 0001601485-26-000032
- 424B5Prospectus supplementFiled · 0001628280-26-017941
- 8-KMaterial event · period of report Mar 12, 2026Filed · 0001601485-26-000026
- 10-KAnnual report · period of report Dec 31, 2025Filed · 0001601485-26-000027
- Form 4Insider transaction · period of report Feb 2, 2026Filed · 0001601485-26-000002
- Form 4Insider transaction · period of report Feb 2, 2026Filed · 0001601485-26-000006
- Form 4Insider transaction · period of report Feb 2, 2026Filed · 0001601485-26-000008
- Form 4Insider transaction · period of report Feb 2, 2026Filed · 0001601485-26-000010
- 10-QQuarterly report · period of report Sep 30, 2025Filed · 0001601485-25-000124
- 10-QQuarterly report · period of report Jun 30, 2025Filed · 0001601485-25-000111
- 10-QQuarterly report · period of report Mar 31, 2025Filed · 0001601485-25-000074
- DEF 14AProxy statement · period of report Apr 9, 2025Filed · 0001601485-25-000062
- Form 3Initial insider ownership · period of report Mar 24, 2025Filed · 0001601485-25-000053
- 10-KAnnual report · period of report Dec 31, 2024Filed · 0001601485-25-000049
- 424B5Prospectus supplementFiled · 0001193125-25-016368
- Form 4/AInsider transaction · period of report Jun 28, 2024Filed · 0001601485-25-000002
- 424B3Updated prospectusFiled · 0001601485-24-000087
- 10-QQuarterly report · period of report Sep 30, 2024Filed · 0001601485-24-000075
- DEF 14AProxy statement · period of report Nov 7, 2024Filed · 0001140361-24-042209
- PRE 14ASEC filing · period of report Nov 7, 2024Filed · 0001140361-24-041303
- SC 13D/A5%+ activist stakeFiled · 0001068238-24-000167
- 10-QQuarterly report · period of report Jun 30, 2024Filed · 0001601485-24-000045
- SC 13D/A5%+ activist stakeFiled · 0001068238-24-000141
- 424B5Prospectus supplementFiled · 0001140361-24-031819
- 424B5Prospectus supplementFiled · 0001140361-24-031588
- 10-QQuarterly report · period of report Mar 31, 2024Filed · 0001601485-24-000033
- 10-K/AAnnual report · period of report Dec 31, 2023Filed · 0001140361-24-022682
Authoritative source
SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.
Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.